跳到主要內容

McGauley Thomas 的 Form 4 申報

Tenax Therapeutics, Inc.(TENX),2025/11/19 申報

申報編號
0001550701-25-000002
申報時間
2025/11/19
交易日
2025/11/17
申報延遲
2 天
10b5-1 計畫
沒有勾選

這份申報列了 3 筆非衍生性交易。公開市場買進合計 $5.82 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
McGauley ThomasCIK 0001550701高階主管(代理財務長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2025/11/17Common StockP買進取得+2,000$7.34F1+$14,6802,000直接
2025/11/17Common StockP買進取得+1,000$7.35+$7,3501,000間接
2025/11/17Common StockP買進取得+5,000$7.23F2+$36,1505,000間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

This transaction was executed in multiple trades at prices ranging from $7.14 to $7.43. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

F2

This transaction was executed in multiple trades at prices ranging from $7.17 to $7.30. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)